YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
5.18
+0.12 (2.27%)
May 15, 2026, 4:00 PM EDT - Market closed
YD Bio Revenue
In the year 2024, YD Bio had annual revenue of $510.36K with 45.76% growth. YD Bio had revenue of $142.69K in the quarter ending December 31, 2024, with 95.63% growth.
Revenue (ttm)
$510.36K
Revenue Growth
+45.76%
P/S Ratio
713.04
Revenue / Employee
n/a
Employees
n/a
Market Cap
363.91M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 510.36K | 160.23K | 45.76% |
| Dec 31, 2023 | 350.13K | -13.99K | -3.84% |
| Dec 31, 2022 | 364.12K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionYDES News
- 17 days ago - YD Bio Limited Reports Full Year 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - YD Bio Ltd trading halted, volatility trading pause - TheFly
- 5 weeks ago - YD Bio Ltd trading resumes - TheFly
- 6 weeks ago - YD Bio and EG BioMed Jointly Launch Nationwide Telehealth Platform to Accelerate Commercialization of Cancer Detection and Decentralized Clinical Services Across the United States - GlobeNewsWire
- 7 weeks ago - YD Bio Ltd trading resumes - TheFly
- 7 weeks ago - YD Bio Ltd trading halted, volatility trading pause - TheFly
- 2 months ago - YD Bio details roadmap for integrated oncology ecosystem - TheFly
- 2 months ago - YD Bio Limited CEO Dr. Ethan Shen Details Strategic Roadmap for Integrated Oncology Ecosystem - GlobeNewsWire